Wegovy 0.25mg FlexTouch is a prescription medicine used for weight loss and weight maintenance in people (18 years and above) who are obese or overweight. It helps reduce the risk of serious heart problems like heart attack or stroke in people with type 2 diabetes and established heart disease.
aids in weight loss and maintenance for overweight or obese adults
Brand
peptide science
Country of Origin
Made in India
Wegovy 1mg FlexTouch is a prescription medicine used for weight loss and weight maintenance in people (18 years and above) who are obese or overweight. It helps reduce the risk of serious heart problems like heart attack or stroke in people with type 2 diabetes and established heart disease
Wegovy 0.5mg FlexTouch is a prescription medicine used for weight loss and weight maintenance in people (18 years and above) who are obese or overweight. It helps reduce the risk of serious heart problems like heart attack or stroke in people with type 2 diabetes and established heart disease.
Tazaro 5 Mg Injection is a combination of two antibiotics. It is used to treat various types of bacterial infections. It fights against the infection by killing the microorganisms.
Tizaro tirzepatide 12.5mg injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. It also indicated for overweight or obesity with or without diabetes.
To treat mild to moderate atopic dermatitis (eczema) i
Country of Origin
Made in India
Ruxolitinib cream 1.5% (OPZELURA™) is a topical formulation of ruxolitinib, a potent, selective inhibitor of Janus kinase (JAK)1 and JAK2. The targeting of these kinases is associated with therapeutic benefits in patients with atopic dermatitis (AD).
Tirzepatide achieved significant weight reduction versus placebo in people with T2D
Storage Conditions
Under 30
It is used together with diet and exercise to help control your blood sugar. Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
